Headquartered in Hungary and founded in 1901, Gedeon Richter Plc. is an innovation-driven specialty pharmaceutical company. The activities of the Hungarian-directed multinational company are vertically integrated and involve pharmaceutical manufacturing, research and development, sales and marketing. Corporate strategy focuses on organic growth complemented with selected acquisitions, primarily in the field of Women’s Healthcare. On a mission to improve the quality of life, the company aims to offer high added value products, both proprietary and biosimilar, in whose manufacturing and development Richter has special knowledge. The company has manufacturing subsidiaries in five countries and markets its products in nearly one hundred countries around the world through its own marketing network. Richter has nearly 13,000 employees and posted sales exceeding EUR 1.6 billion in 2020 reasonably priced treatments in almost every therapeutic area. The company focuses on developing and manufacturing central nervous system, cardiovascular and gynaecological products.